Here are relevant reports on : biotechnology-market
-
Laboratory Balances and Scales Market by Product (Balances (Analytical, Precision, Micro, Portable, Moisture), Scales (Bench, Counting, Compact)), End User (Pharmaceutical, Biotechnology, Chemical, Beverage, Petroleum, Academia) - Global Forecasts to 2023
The Laboratory Balances and Scales Market is projected to reach USD 1.6 billion by 2023, growing at a CAGR of 3.7%. Growth in the lab balances and scales market is primarily driven by factors such as technological advancements in laboratory balances and scales; expansion of research pipeline among pharma-biotech and CROs; increasingly stringent regulatory framework for product safety in biotechnology and pharmaceutical industries; and growing public emphasis on Implementation of stringent food safety guidelines. The major players operating in the lab balances and scales market are A&D Company, Ltd (Japan), Metler Toledo international, Inc. (US), Sartorius AG (Germany), Shimadzu Corporation (Japan), PCE Instruments (UK), Kern & Sohn GmbH (Germany), RADWAG Balances and Scales (Poland), Adam Equipment Co. (UK), Avery Weigh-Tronix, LLC (UK), Bonso Electronics International, Inc. (China), Essae Group (India), and Gram Precision S.L (Spain).
- Published: November 2018
- Price: $ 4950
- TOC Available:
-
Atomic Spectroscopy Market by Technology (Atomic Absorption Spectroscopy/X-Ray Fluorescence/X-Ray Diffraction/ICP-MS/ICP-OES) & by Application (Food & Beverage Testing/Pharmaceuticals & Biotechnology / Environmental Testing) - Analysis & Global Forecast to 2020
The atomic spectroscopy market is poised to reach USD 5.60 Billion by 2020, growing at a CAGR of 6.0% during the forecast period of 2015 to 2020. The growth of the overall atomic spectroscopy market can be contributed to rising investments, funds, and grants by government bodies worldwide and technological advancements. In addition, growing food safety concerns and stringent regulations have contributed to market growth.
- Published: January 2016
- Price: $ 4950
- TOC Available:
-
Electronic Trial Master File (eTMF) Systems Market by Component (Services, Software), End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations), Delivery Mode (On-Premise, Cloud-Based), and Region - Global Forecast to 2024
The Electronic Trial Master File (eTMF) Systems Market is expected to grow from USD 1.0 billion in 2019 to USD 1.8 billion by 2024, at a CAGR of 12.7% during the forecast period. Veeva Systems (US), Oracle Corporation (US), Phlexglobal Limited (UK), TransPerfect Global Inc. (US), Aurea Software (US), LabCorp (US), ePharmaSolutions (US), Wingspan Technology, Inc. (US), MasterControl (US), SureClinical, Inc. (US), Dell EMC (US), Paragon Solutions (US), PharmaVigilant (US), Mayo Clinic (US), Database Integrations, Inc. (US), CareLex (US), Ennov (France), Forte Research (US), Freyr (US), Montrium (US), NCGS Inc. (US), SAFE-BioPharma (US), SterlingBio Inc. (US), BIOVIA Corp. (US), and arivis AG (Germany) are the key players in the eTMF systems market.
- Published: August 2019
- Price: $ 4950
- TOC Available:
-
Biotechnology Instruments Market by Product (LC, NGS, Mass Spectrometry, Electrophoresis, Bioreactors, Incubators, Centrifuges, Spectrophotometers), Application (Biotech Manufacturing, Spatial Cell Analysis, Genomics, Proteomics), End User (Biopharma Cos, CROs, Academia) - Global Forecasts to 2027
The global biotechnology instruments market is projected to reach USD 35.9 billion by 2027 from USD 21.4 billion in 2022, at a CAGR of 9% during the forecast period
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes)
The global antibody production market size is projected grow at a CAGR of 12.3%. The market is segmented on the basis of process and end users. By process, the market is segmented into upstream processing, downstream processing, and filtration.
- Published: August 2016
- Price: $ 4950
- TOC Available:
-
Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) - Global Forecasts to 2023
The global cell harvesting market is expected to reach USD 324.5 Million by 2023, at a CAGR of 8.7%. Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Cell Lysis Market / Fractionation Market by Product (Consumables (Enzymes, Detergent), Instruments (Sonicators)), Cell Type (Mammalian), Application (Protein Purification), End User (Biopharmaceutical & Biotechnology Companies) & Region - Global Forecast to 2026
The global cell lysis market growth is primed to transition from $2.9 billion in 2021 to $4.1 billion by 2026, showcasing a strong CAGR of 7.2%. Growth of the market is driven mainly by increasing government funding for research, the high prevalence of diseases, and a growing focus on personalised medicine.
- Published: March 2021
- Price: $ 4950
- TOC Available:
-
Precision Medicine Software Market by Delivery Mode (On-Premise & Cloud-Based), End User (Healthcare Providers, Research Centers & Government Institutes, Pharmaceutical & Biotechnology Companies), Application, and Region - Global Forecast to 2024
The precision medicine software market is projected to reach USD 2.0 billion by 2024, at a CAGR of 11.5%. Factors such as the rising government funding in precision medicine initiatives, partnerships among pharmaceutical and software companies, the entry of new players & VC funding, and growth in the number of cancer patients are driving the growth of the precision medicine software market. However, the high cost of deployment, issues related to the secure storage of large volumes of sequenced data, lack of reimbursement for precision medicine-based treatments, and the dearth of skilled IT professionals in healthcare are expected to restrain market growth to a certain extent in the coming years. Syapse, Inc. (US), 2bPrecise LLC (Israel), Foundation Medicine, Inc. (US), Fabric Genomics (US), SOPHiA GENETICS SA (Switzerland), PierianDx, Inc. (US), N-of-One, Inc. (US), Human Longevity, Inc. (US), Translational Software, Inc. (US), Sunquest Information Systems Inc. (US), Gene42, Inc. (Canada), LifeOmic Health, LLC (US), NantHealth, Inc. (US), Tempus Labs, Inc. (US), Flatiron Health, Inc. (US), IBM Watson Group (US), and Koninklijke Philips N.V. (Netherlands)
- Published: March 2019
- Price: $ 4950
- TOC Available:
-
Biotechnology Up-Stream & Down-Stream Processing Technology Analysis-Competitive Landscape Market - 2019 By Types, Application & Geography Current Trends & Technologies
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
HPC Data Management Market in Life Sciences By Products & Services (Data Analysis, Cloud Computing), Applications (NGS, Microscopy, Chromatography), End User (Pharmaceutical & Biotechnology, Hospitals) - Global Forecast to 2024
The HPC Data Management Market in life sciences is projected to reach USD 41.1 billion by 2024, at a CAGR of 17.1%. The growth of this market is majorly driven by the growing demand for data storage and management solutions due to extensive amount of data generated through large number of research activities. However, the high cost of implementation and regulatory hurdles are major factors restraining the growth of this market.Dell Technologies Inc. (US), Advanced Micro Devices, Inc. (US), Cray, Inc. (US), Cisco Systems, Inc. (US), IBM Corporation (US), Intel Corporation (US), Lenovo Group Limited (China), Hewlett Packard Enterprise Company (US).
- Published: April 2019
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50